- Home
- ACET vs VRA Comparison
ACET vs VRA Comparison
Compare ACET & VRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- VRA
- Stock Information
- Founded
- ACET 1947
- VRA 1982
- Country
- ACET United States
- VRA United States
- Employees
- ACET N/A
- VRA N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- VRA Apparel
- Sector
- ACET Health Care
- VRA Consumer Discretionary
- Exchange
- ACET Nasdaq
- VRA Nasdaq
- Market Cap
- ACET 83.2M
- VRA 69.2M
- IPO Year
- ACET N/A
- VRA 2010
- Fundamental
- Price
- ACET $0.89
- VRA $2.41
- Analyst Decision
- ACET Buy
- VRA Strong Buy
- Analyst Count
- ACET 6
- VRA 2
- Target Price
- ACET $6.00
- VRA $4.00
- AVG Volume (30 Days)
- ACET 414.2K
- VRA 273.6K
- Earning Date
- ACET 03-06-2025
- VRA 03-12-2025
- Dividend Yield
- ACET N/A
- VRA N/A
- EPS Growth
- ACET N/A
- VRA N/A
- EPS
- ACET N/A
- VRA N/A
- Revenue
- ACET N/A
- VRA $371,967,000.00
- Revenue This Year
- ACET N/A
- VRA $8.22
- Revenue Next Year
- ACET N/A
- VRA $9.15
- P/E Ratio
- ACET N/A
- VRA N/A
- Revenue Growth
- ACET N/A
- VRA N/A
- 52 Week Low
- ACET $0.74
- VRA $2.15
- 52 Week High
- ACET $2.43
- VRA $8.32
- Technical
- Relative Strength Index (RSI)
- ACET 55.27
- VRA 36.06
- Support Level
- ACET $0.74
- VRA $2.32
- Resistance Level
- ACET $0.81
- VRA $2.80
- Average True Range (ATR)
- ACET 0.06
- VRA 0.26
- MACD
- ACET 0.01
- VRA -0.01
- Stochastic Oscillator
- ACET 71.29
- VRA 27.03
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.